Tekla Life Sciences Investors of Benef Interest
Name
As of 03/26/2024Price
Aum/Mkt Cap
YIELD
Exp Ratio
Watchlist
Vitals
YTD Return
-1.3%
1 yr return
1.3%
3 Yr Avg Return
-7.9%
5 Yr Avg Return
-2.2%
Net Assets
$390 M
Holdings in Top 10
50.6%
52 WEEK LOW AND HIGH
Expenses
OPERATING FEES
Expense Ratio 1.24%
SALES FEES
Front Load N/A
Deferred Load N/A
TRADING FEES
Turnover 62.37%
Redemption Fee N/A
Min Investment
Standard (Taxable)
N/A
IRA
N/A
Fund Classification
Fund Type
Closed-end mutual fund
Name
As of 03/26/2024Price
Aum/Mkt Cap
YIELD
Exp Ratio
Watchlist
XHQLX - Profile
Distributions
- YTD Total Return -1.3%
- 3 Yr Annualized Total Return -7.9%
- 5 Yr Annualized Total Return -2.2%
- Capital Gain Distribution Frequency N/A
- Net Income Ratio -0.80%
- Dividend Yield 0.0%
- Dividend Distribution Frequency Quarterly
Fund Details
-
Legal NameTekla Life Sciences Investors of Benef Interest
-
Fund Family NameTekla Capital Management LLC
-
Inception DateNov 22, 2011
-
Shares Outstanding25144038
-
Share ClassOther
-
CurrencyUSD
-
Domiciled CountryUnited States
-
ManagerDaniel Omstead
Fund Description
XHQLX - Performance
Return Ranking - Trailing
Period | XHQLX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
YTD | -1.3% | -15.0% | 17.3% | 94.48% |
1 Yr | 1.3% | -20.2% | 35.0% | 91.41% |
3 Yr | -7.9%* | -30.8% | 14.0% | 91.03% |
5 Yr | -2.2%* | -3.5% | 14.3% | 99.26% |
10 Yr | 0.7%* | 0.2% | 14.1% | 99.07% |
* Annualized
Return Ranking - Calendar
Period | XHQLX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
2023 | -2.2% | -12.6% | 19.0% | 82.21% |
2022 | -15.6% | -53.9% | 3.2% | 73.72% |
2021 | -9.3% | -39.6% | 24.2% | 71.79% |
2020 | 10.9% | -13.6% | 178.2% | 62.91% |
2019 | 17.0% | 3.8% | 63.8% | 77.78% |
Total Return Ranking - Trailing
Period | XHQLX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
YTD | -1.3% | -15.0% | 17.3% | 94.48% |
1 Yr | 1.3% | -20.2% | 35.0% | 91.41% |
3 Yr | -7.9%* | -30.8% | 14.0% | 91.03% |
5 Yr | -2.2%* | -3.5% | 14.3% | 99.26% |
10 Yr | 0.7%* | 0.2% | 14.1% | 99.07% |
* Annualized
Total Return Ranking - Calendar
Period | XHQLX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
2023 | -2.2% | -12.6% | 19.0% | 88.34% |
2022 | -15.6% | -53.9% | 3.7% | 79.49% |
2021 | -9.3% | -33.9% | 26.0% | 88.46% |
2020 | 10.9% | -0.7% | 180.6% | 92.05% |
2019 | 21.6% | 4.6% | 63.8% | 79.26% |
NAV & Total Return History
XHQLX - Holdings
Concentration Analysis
XHQLX | Category Low | Category High | XHQLX % Rank | |
---|---|---|---|---|
Net Assets | 390 M | 6.16 M | 45 B | 57.67% |
Number of Holdings | 145 | 23 | 413 | 10.43% |
Net Assets in Top 10 | 247 M | 2.07 M | 20.4 B | 57.06% |
Weighting of Top 10 | 50.56% | 18.1% | 77.0% | 41.10% |
Top 10 Holdings
- Moderna Inc 7.94%
- Gilead Sciences Inc 7.64%
- Amgen Inc 6.91%
- Regeneron Pharmaceuticals Inc 5.61%
- Illumina Inc 5.02%
- Horizon Therapeutics PLC 4.83%
- Seagen Inc Ordinary Shares 4.64%
- Vertex Pharmaceuticals Inc 4.30%
- Alexion Pharmaceuticals Inc 4.15%
- Biogen Inc 4.00%
Asset Allocation
Weighting | Return Low | Return High | XHQLX % Rank | |
---|---|---|---|---|
Stocks | 91.87% | 87.17% | 106.13% | 89.57% |
Preferred Stocks | 7.86% | 0.00% | 7.86% | 0.61% |
Cash | 2.51% | 0.00% | 32.99% | 43.56% |
Convertible Bonds | 0.00% | 0.00% | 0.37% | 40.51% |
Bonds | 0.00% | 0.00% | 12.39% | 42.33% |
Other | -2.25% | -22.99% | 17.73% | 98.77% |
Stock Sector Breakdown
Weighting | Return Low | Return High | XHQLX % Rank | |
---|---|---|---|---|
Healthcare | 99.82% | 59.26% | 100.00% | 55.70% |
Financial Services | 0.18% | 0.00% | 1.60% | 16.46% |
Utilities | 0.00% | 0.00% | 0.00% | 36.08% |
Technology | 0.00% | 0.00% | 22.69% | 41.14% |
Real Estate | 0.00% | 0.00% | 5.89% | 39.87% |
Industrials | 0.00% | 0.00% | 7.02% | 40.51% |
Energy | 0.00% | 0.00% | 0.00% | 36.08% |
Communication Services | 0.00% | 0.00% | 9.11% | 39.24% |
Consumer Defense | 0.00% | 0.00% | 25.73% | 44.30% |
Consumer Cyclical | 0.00% | 0.00% | 1.92% | 40.51% |
Basic Materials | 0.00% | 0.00% | 7.16% | 56.33% |
Stock Geographic Breakdown
Weighting | Return Low | Return High | XHQLX % Rank | |
---|---|---|---|---|
US | 83.97% | 66.21% | 104.41% | 77.91% |
Non US | 7.90% | 0.00% | 29.78% | 29.45% |
XHQLX - Expenses
Operational Fees
XHQLX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Expense Ratio | 1.24% | 0.08% | 4.28% | 39.88% |
Management Fee | 0.98% | 0.03% | 1.25% | 90.18% |
12b-1 Fee | N/A | 0.00% | 1.00% | N/A |
Administrative Fee | N/A | 0.03% | 0.25% | N/A |
Sales Fees
XHQLX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Front Load | N/A | 3.50% | 5.75% | N/A |
Deferred Load | N/A | 1.00% | 5.00% | N/A |
Trading Fees
XHQLX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Max Redemption Fee | N/A | 1.00% | 1.00% | N/A |
Related Fees
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
XHQLX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Turnover | 62.37% | 0.00% | 238.00% | 78.99% |
XHQLX - Distributions
Dividend Yield Analysis
XHQLX | Category Low | Category High | XHQLX % Rank | |
---|---|---|---|---|
Dividend Yield | 0.00% | 0.00% | 6.95% | 59.51% |
Dividend Distribution Analysis
XHQLX | Category Low | Category High | Category Mod | |
---|---|---|---|---|
Dividend Distribution Frequency | Quarterly | Annual | Monthly | Annual |
Net Income Ratio Analysis
XHQLX | Category Low | Category High | XHQLX % Rank | |
---|---|---|---|---|
Net Income Ratio | -0.80% | -2.54% | 1.85% | 84.62% |
Capital Gain Distribution Analysis
XHQLX | Category Low | Category High | Capital Mode | |
---|---|---|---|---|
Capital Gain Distribution Frequency | Annually | Annually | Annually |
Distributions History
Date | Amount | Type |
---|---|---|
Jun 28, 2019 | $0.370 | OrdinaryDividend |
Mar 29, 2019 | $0.330 | OrdinaryDividend |
Dec 31, 2018 | $0.420 | OrdinaryDividend |
Sep 28, 2018 | $0.400 | OrdinaryDividend |
Jun 29, 2018 | $0.400 | OrdinaryDividend |
Mar 29, 2018 | $0.400 | OrdinaryDividend |
Dec 29, 2017 | $0.430 | OrdinaryDividend |
Sep 29, 2017 | $0.420 | OrdinaryDividend |
Jun 30, 2017 | $0.410 | OrdinaryDividend |
Mar 31, 2017 | $0.360 | OrdinaryDividend |
Dec 30, 2016 | $0.400 | OrdinaryDividend |
Aug 12, 2016 | $0.820 | OrdinaryDividend |
Jun 10, 2016 | $0.370 | OrdinaryDividend |
Mar 31, 2016 | $0.480 | OrdinaryDividend |
Jan 08, 2016 | $0.710 | ExtraDividend |
Dec 31, 2015 | $0.457 | OrdinaryDividend |
Sep 30, 2015 | $0.564 | OrdinaryDividend |
Jun 30, 2015 | $0.525 | OrdinaryDividend |
Mar 31, 2015 | $0.486 | OrdinaryDividend |
Dec 31, 2014 | $0.457 | OrdinaryDividend |
Sep 30, 2014 | $0.437 | OrdinaryDividend |
Jun 30, 2014 | $0.418 | OrdinaryDividend |
Mar 31, 2014 | $0.408 | OrdinaryDividend |
Dec 31, 2013 | $0.389 | OrdinaryDividend |
Sep 30, 2013 | $0.340 | OrdinaryDividend |
Jun 28, 2013 | $0.330 | OrdinaryDividend |
Mar 28, 2013 | $0.292 | OrdinaryDividend |
Dec 31, 2012 | $0.301 | OrdinaryDividend |
Sep 28, 2012 | $0.292 | OrdinaryDividend |
Jun 29, 2012 | $0.282 | OrdinaryDividend |
Mar 30, 2012 | $0.253 | OrdinaryDividend |
Dec 30, 2011 | $0.622 | OrdinaryDividend |
Sep 30, 2011 | $0.262 | OrdinaryDividend |
Jun 30, 2011 | $0.253 | OrdinaryDividend |
Mar 31, 2011 | $0.243 | OrdinaryDividend |
Dec 30, 2010 | $0.224 | OrdinaryDividend |
Sep 30, 2010 | $0.126 | OrdinaryDividend |
Jun 30, 2010 | $0.156 | OrdinaryDividend |
Jun 30, 2009 | $0.194 | OrdinaryDividend |
Mar 31, 2009 | $0.214 | OrdinaryDividend |
Dec 31, 2008 | $0.253 | OrdinaryDividend |
Sep 30, 2008 | $0.253 | OrdinaryDividend |
Jun 30, 2008 | $0.262 | OrdinaryDividend |
Mar 31, 2008 | $0.301 | OrdinaryDividend |
Dec 31, 2007 | $0.301 | OrdinaryDividend |
Sep 28, 2007 | $0.282 | OrdinaryDividend |
Jun 29, 2007 | $0.282 | OrdinaryDividend |
Mar 30, 2007 | $0.272 | OrdinaryDividend |
Dec 29, 2006 | $0.272 | OrdinaryDividend |
Sep 29, 2006 | $0.282 | OrdinaryDividend |
Jun 30, 2006 | $0.340 | OrdinaryDividend |
Mar 30, 2006 | $0.311 | OrdinaryDividend |
Dec 30, 2005 | $1.059 | OrdinaryDividend |
Sep 30, 2005 | $0.321 | OrdinaryDividend |
Jun 30, 2005 | $0.301 | OrdinaryDividend |
Mar 30, 2005 | $0.321 | OrdinaryDividend |
Dec 30, 2004 | $0.311 | OrdinaryDividend |
Sep 28, 2004 | $0.329 | OrdinaryDividend |
Jun 29, 2004 | $0.350 | OrdinaryDividend |
Mar 30, 2004 | $0.330 | OrdinaryDividend |
Dec 31, 2003 | $0.330 | OrdinaryDividend |
Sep 25, 2003 | $0.321 | OrdinaryDividend |
Jun 27, 2003 | $0.272 | OrdinaryDividend |
Mar 26, 2003 | $0.282 | OrdinaryDividend |
Dec 27, 2002 | $0.874 | OrdinaryDividend |
Sep 20, 2002 | $0.330 | OrdinaryDividend |
Jun 27, 2002 | $0.418 | OrdinaryDividend |
Mar 26, 2002 | $0.496 | OrdinaryDividend |
Dec 21, 2001 | $1.535 | OrdinaryDividend |
Jun 20, 2001 | $0.437 | OrdinaryDividend |
Mar 23, 2001 | $0.525 | OrdinaryDividend |
Dec 27, 2000 | $2.303 | OrdinaryDividend |
Sep 27, 2000 | $0.700 | OrdinaryDividend |
Jun 27, 2000 | $0.602 | OrdinaryDividend |
Mar 27, 2000 | $0.437 | OrdinaryDividend |
XHQLX - Fund Manager Analysis
Managers
Daniel Omstead
Start Date
Tenure
Tenure Rank
Sep 30, 2001
20.68
20.7%
Omstead is president and chief executive officer of Tekla Capital Management, formerly known as Hambrecht & Quist Capital Management, Inc. Before joining the adviser, Omstead was president and CEO of Reprogenesis, Inc., a private development stage biotech company developing therapies in the field of regenerative medicine. Before joining Reprogenesis, he was senior vice president, research and development at Cytotherapeutics, Inc., a public biotech company that developed CNS therapies.
Tenure Analysis
Category Low | Category High | Category Average | Category Mode |
---|---|---|---|
0.02 | 24.72 | 7.84 | 0.25 |